Shuai Wu

Also affiliated with South China University of Technology

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 6 papers. Top paper: “Targeting glutamine dependence through GLS1 inhibition suppresses ARID1A-inactivated clear cell ovarian carcinoma”.

Targeting glutamine dependence through GLS1 inhibition suppresses ARID1A-inactivated clear cell ovarian carcinoma

Nature Cancer(2021)10.1038/s43018-020-00160-x

N/A

0DataRank · unranked

125 citations

Takeshi Fukumoto, Jianhuang Lin, Timothy Nacarelli, Yemin Wang, Dionzie Ong +16 more

Targeting the IRE1α/XBP1s pathway suppresses CARM1-expressing ovarian cancer

Nature Communications(2021)10.1038/s41467-021-25684-3

N/A

0DataRank · unranked

52 citations

Heng Liu, Takeshi Fukumoto, Joseph A. Zundell, Qingqing Yan, Chih-Hang Anthony Tang +9 more

Targeting the IRE1α/XBP1 Endoplasmic Reticulum Stress Response Pathway in ARID1A -Mutant Ovarian Cancers

Cancer Research(2021)10.1158/0008-5472.can-21-1545

N/A

0DataRank · unranked

32 citations

Takeshi Fukumoto, Jianhuang Lin, Nail Fatkhudinov, Timothy Nacarelli, Andrew V. Kossenkov +6 more

Data from Targeting the IRE1α/XBP1 Endoplasmic Reticulum Stress Response Pathway in ARID1A-Mutant Ovarian Cancers

(2023)10.1158/0008-5472.c.6513601.v1

N/A

0DataRank · unranked

0 citations

Takeshi Fukumoto, Jianhuang Lin, Nail Fatkhudinov, Timothy Nacarelli, Andrew V. Kossenkov +6 more

The structural basis for 2’-5’/3’-5’-cGAMP synthesis by cGAS

Research Square(2023)10.21203/rs.3.rs-2986580/v1

N/A

0DataRank · unranked

0 citations

Sandra B. Gabelli, Jungsan Sohn, Shuai Wu

Selective Alanine Transporter Utilization Is a Therapeutic Vulnerability in ARID1A-Mutant Ovarian Cancer

Cancer Research(2025)10.1158/0008-5472.can-25-0654

N/A

0DataRank · unranked

3 citations

Liping Liao, Rafał Zieliński, Javier A. Gomez, Akshay V. Basi, Erin H. Seeley +22 more